Bohnen Shane 4

What Happened
Shane Bohnen, SVP and General Counsel of Bio-Techne (TECH), exercised options to acquire 8,400 shares on 2026-05-05. The exercise price was $47.60 per share (cost = $399,840). To cover taxes/exercise obligations, 7,055 of the acquired shares were surrendered/withheld at a market price of $56.68 per share (value = $399,877). After the sell-to-cover withholding, Bohnen received a net 1,345 shares. The filing shows this as an option exercise (code M) with tax withholding/surrender (code F).

Key Details

• Transaction date: 2026-05-05; Form 4 filed 2026-05-07 (timely).
• Option exercise: 8,400 shares acquired at $47.60 each (total $399,840).
• Withholding/tax surrender: 7,055 shares withheld/disposed at $56.68 each (value $399,877).
• Net shares issued to insider: 1,345 shares (8,400 − 7,055).
• Notable footnote: F1 — the options exercised were fully exercisable. Other footnotes in the filing describe vesting schedules for other awards but do not change this exercise.
• Shares owned after the transaction: not specified in the excerpt provided.

Context
This was a cashless/sell-to-cover option exercise: the insider exercised options and surrendered most of the resulting shares to satisfy exercise price and tax withholding rather than paying cash. Such transactions are common for option exercises and are generally routine administrative actions rather than an explicit buy or sell market opinion. Transaction codes: M = option exercise/conversion; F = payment of exercise price or tax liability.